These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7499276)

  • 21. Disruption of imprinted genes at chromosome region 11p15.5 in paediatric rhabdomyosarcoma.
    Anderson J; Gordon A; McManus A; Shipley J; Pritchard-Jones K
    Neoplasia; 1999 Oct; 1(4):340-8. PubMed ID: 10935489
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Occasional loss of constitutive heterozygosity at 11p15.5 and imprinting relaxation of the IGFII maternal allele in hepatoblastoma.
    Montagna M; Menin C; Chieco-Bianchi L; D'Andrea E
    J Cancer Res Clin Oncol; 1994; 120(12):732-6. PubMed ID: 7798299
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential biallelic activation of three insulin-like growth factor II promoters in the mouse central nervous system.
    Hu JF; Vu TH; Hoffman AR
    Mol Endocrinol; 1995 May; 9(5):628-36. PubMed ID: 7565809
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypomethylation of the P3 promoter is associated with up-regulation of IGF2 expression in human osteosarcoma.
    Li Y; Meng G; Huang L; Guo QN
    Hum Pathol; 2009 Oct; 40(10):1441-7. PubMed ID: 19427670
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Maintenance of genomic imprinting at the IGF2 locus in hepatoblastoma.
    Davies SM
    Cancer Res; 1993 Oct; 53(20):4781-3. PubMed ID: 8402661
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression and parental imprinting of the H19 gene in human rhabdomyosarcoma.
    Casola S; Pedone PV; Cavazzana AO; Basso G; Luksch R; d'Amore ES; Carli M; Bruni CB; Riccio A
    Oncogene; 1997 Mar; 14(12):1503-10. PubMed ID: 9136994
    [TBL] [Abstract][Full Text] [Related]  

  • 27. AP-2 may contribute to IGF-II overexpression in rhabdomyosarcoma.
    Zhang L; Zhan S; Navid F; Li Q; Choi YH; Kim M; Seth P; Helman LJ
    Oncogene; 1998 Sep; 17(10):1261-70. PubMed ID: 9771969
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Altered transcriptional regulation of the insulin-like growth factor 2 gene in human hepatocellular carcinoma.
    Uchida K; Kondo M; Takeda S; Osada H; Takahashi T; Nakao A; Takahashi T
    Mol Carcinog; 1997 Apr; 18(4):193-8. PubMed ID: 9142213
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relaxation of insulin-like growth factor-II gene imprinting in human gynecologic tumors.
    Yaginuma Y; Nishiwaki K; Kitamura S; Hayashi H; Sengoku K; Ishikawa M
    Oncology; 1997; 54(6):502-7. PubMed ID: 9394848
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Initial characterization of the four promoters of the human insulin-like growth factor II gene.
    van Dijk MA; van Schaik FM; Bootsma HJ; Holthuizen P; Sussenbach JS
    Mol Cell Endocrinol; 1991 Oct; 81(1-3):81-94. PubMed ID: 1797589
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relaxation of imprinting of IGFII gene in juvenile nasopharyngeal angiofibromas.
    Coutinho-Camillo CM; Brentani MM; Butugan O; Torloni H; Nagai MA
    Diagn Mol Pathol; 2003 Mar; 12(1):57-62. PubMed ID: 12605037
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Altered genomic imprinting in the IGF2 and H19 genes in human lung cancer].
    Kondo M; Takahashi T
    Nihon Rinsho; 1996 Feb; 54(2):492-6. PubMed ID: 8838103
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Loss of imprinting of IGF2 in Ewing's sarcoma.
    Zhan S; Shapiro DN; Helman LJ
    Oncogene; 1995 Dec; 11(12):2503-7. PubMed ID: 8545106
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insulin-like growth factor 2 expression in prostate cancer is regulated by promoter-specific methylation.
    Küffer S; Gutting T; Belharazem D; Sauer C; Michel MS; Marx A; Trojan L; Ströbel P
    Mol Oncol; 2018 Feb; 12(2):256-266. PubMed ID: 29239100
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of an imprinted allele of the insulin-like growth factor II gene implicated in rhabdomyosarcoma.
    Zhan S; Shapiro DN; Helman LJ
    J Clin Invest; 1994 Jul; 94(1):445-8. PubMed ID: 8040287
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genomic deletion of an imprint maintenance element abolishes imprinting of both insulin-like growth factor II and H19.
    Hu JF; Vu TH; Hoffman AR
    J Biol Chem; 1997 Aug; 272(33):20715-20. PubMed ID: 9252392
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Promoter-specific transcription of insulin-like growth factor-II in epithelial ovarian cancer.
    Lu L; Katsaros D; Wiley A; Rigault de la Longrais IA; Puopolo M; Schwartz P; Yu H
    Gynecol Oncol; 2006 Dec; 103(3):990-5. PubMed ID: 16859738
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Establishment of functional imprinting of the H19 gene in human developing placentae.
    Jinno Y; Ikeda Y; Yun K; Maw M; Masuzaki H; Fukuda H; Inuzuka K; Fujishita A; Ohtani Y; Okimoto T
    Nat Genet; 1995 Jul; 10(3):318-24. PubMed ID: 7670470
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Switch from monoallelic to biallelic human IGF2 promoter methylation during aging and carcinogenesis.
    Issa JP; Vertino PM; Boehm CD; Newsham IF; Baylin SB
    Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11757-62. PubMed ID: 8876210
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activation of fetal promoters of insulinlike growth factors II gene in hepatitis C virus-related chronic hepatitis, cirrhosis, and hepatocellular carcinoma.
    Nardone G; Romano M; Calabrò A; Pedone PV; de Sio I; Persico M; Budillon G; Bruni CB; Riccio A; Zarrilli R
    Hepatology; 1996 Jun; 23(6):1304-12. PubMed ID: 8675143
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.